Business, energy, technology, markets and global industry news from Business News Today

anti-CD20 therapy

PharmaDeviceNews anti-CD20 therapy
Pharma & Biotech

What TG Therapeutics, Inc.’s AAN 2026 updates reveal about real-world performance of BRIUMVI in multiple sclerosis

Explore how TG Therapeutics, Inc.’s BRIUMVI data at AAN 2026 could reshape real-world MS treatment and adoption trends. Read the full analysis now.

Read More
Pharma & Biotech

FDA accepts Genentech’s Gazyva application for SLE, what it means for lupus treatment

FDA accepts Genentech’s Gazyva filing for systemic lupus erythematosus. Read what the ALLEGORY data could mean for lupus treatment in 2026.

Read More
Pharma & Biotech

What TG Therapeutics’ ACTRIMS strategy signals about the next competitive phase in anti-CD20 multiple sclerosis therapy

Find out how TG Therapeutics’ ACTRIMS strategy reshapes competition in anti-CD20 multiple sclerosis therapy and what clinicians and regulators are watching next.

Read More